IL186634A0 - Compositions facilitating drug penetration and drug retention in skin - Google Patents

Compositions facilitating drug penetration and drug retention in skin

Info

Publication number
IL186634A0
IL186634A0 IL186634A IL18663407A IL186634A0 IL 186634 A0 IL186634 A0 IL 186634A0 IL 186634 A IL186634 A IL 186634A IL 18663407 A IL18663407 A IL 18663407A IL 186634 A0 IL186634 A0 IL 186634A0
Authority
IL
Israel
Prior art keywords
drug
skin
retention
penetration
compositions facilitating
Prior art date
Application number
IL186634A
Other languages
English (en)
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of IL186634A0 publication Critical patent/IL186634A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
IL186634A 2005-04-13 2007-10-14 Compositions facilitating drug penetration and drug retention in skin IL186634A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67064105P 2005-04-13 2005-04-13
PCT/US2006/013496 WO2006113227A2 (fr) 2005-04-13 2006-04-11 Compositions facilitant la penetration et la retention de medicament dans la peau

Publications (1)

Publication Number Publication Date
IL186634A0 true IL186634A0 (en) 2008-01-20

Family

ID=37115666

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186634A IL186634A0 (en) 2005-04-13 2007-10-14 Compositions facilitating drug penetration and drug retention in skin

Country Status (2)

Country Link
IL (1) IL186634A0 (fr)
WO (1) WO2006113227A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
EP1970051A1 (fr) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Utilisation d'une micro-émulsion aqueuse pour la préparation d'une formulation pour le traitement de maladies adipeuses
EP2666456A1 (fr) * 2012-05-21 2013-11-27 Natura Bisse International, S.A. Compositions cosmétiques comprenant des magnetosomes et utilisations associées
GB201620701D0 (en) * 2016-12-06 2017-01-18 Glaxosmithkline Consumer Healthcare (Uk) Ip Ltd Novel composition
DE102018113509A1 (de) 2018-06-06 2019-12-12 Philipps-Universität Marburg Mikroemulsion zur dermalen Hyposensibilisierung mit Allergenen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US8728445B2 (en) * 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions

Also Published As

Publication number Publication date
WO2006113227A2 (fr) 2006-10-26
WO2006113227A3 (fr) 2007-02-22

Similar Documents

Publication Publication Date Title
GB0523576D0 (en) Drug composition and its use in therapy
GB2437875B (en) Skin care composition comprising L-carnosine and N-acetylcysteine
EP1951762A4 (fr) Préparations et méthodes pour soin de la peau amélioré
IL188420A0 (en) Methods and compositions with enhanced therapeutic activity
GB0422525D0 (en) Dermatological compositions and methods
EP1895946A4 (fr) Ameliorations d'implants chirurgicaux
IL192198A0 (en) Skin care compositions and treatments
IL173091A0 (en) Cosmetic and pharmaceutical foam with solid matter
EP1879449A4 (fr) Compositions et procedes de soin de la peau
HK1112427A1 (en) Drug delivery compositions and related methods
IL188222A (en) Immunological preparations and their use in vaccinating animals against tuberculosis
IL191072A0 (en) Therapeutic compositions and methods
GB0514891D0 (en) Improvements in and relating to implants
ZA200708530B (en) Pharmaceutical composition and method using antifungal agent in combination
IL186634A0 (en) Compositions facilitating drug penetration and drug retention in skin
IL195493A0 (en) Combination preparations comprising bifeprunox and l-dopa
GB0508755D0 (en) Improvement in and relating to catheter needles
GB0406835D0 (en) Improvements in and relating to implants
EP2034829A4 (fr) Composition pharmaceutique comprenant la cyclobenzaprine et l'acéclofénac en association
GB0523166D0 (en) Improvements in and relating to medical products
GB0516962D0 (en) Improvements in and relating to investigations
EP1812032A4 (fr) Composition a base de facteur tissulaire et methodes associees
GB0718156D0 (en) Improvements in and relating to investigations
GB0406014D0 (en) Pharmaceutical composition and use
GB0523577D0 (en) Drug composition and its use in therapy